These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30846165)

  • 1. Fibrous Cephalic Plaque in Tuberous Sclerosis Complex: Treatment With 0.2% Rapamycin.
    Giacaman A; Martín-Santiago A
    Actas Dermosifiliogr (Engl Ed); 2019 Jun; 110(5):e13. PubMed ID: 30846165
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of subungual fibromas of tuberous sclerosis with topical rapamycin.
    Muzic JG; Kindle SA; Tollefson MM
    JAMA Dermatol; 2014 Sep; 150(9):1024-5. PubMed ID: 24919623
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin.
    Koenig MK; Hebert AA; Roberson J; Samuels J; Slopis J; Woerner A; Northrup H
    Drugs R D; 2012 Sep; 12(3):121-6. PubMed ID: 22934754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex.
    Wataya-Kaneda M; Tanaka M; Yang L; Yang F; Tsuruta D; Nakamura A; Matsumoto S; Hamasaki T; Tanemura A; Katayama I
    JAMA Dermatol; 2015 Jul; 151(7):722-30. PubMed ID: 25692384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients.
    Malissen N; Vergely L; Simon M; Roubertie A; Malinge MC; Bessis D
    J Am Acad Dermatol; 2017 Sep; 77(3):464-472.e3. PubMed ID: 28502378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberous sclerosis with two unusual findings: cutaneous rhabdomyoma and chronic myelogenous leukaemia.
    Bardawil T; El Jamal L; Abbas O; Kurban M
    Clin Exp Dermatol; 2020 Aug; 45(6):799-801. PubMed ID: 32097503
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus.
    Nathan N; Wang JA; Li S; Cowen EW; Haughey M; Moss J; Darling TN
    J Am Acad Dermatol; 2015 Nov; 73(5):802-8. PubMed ID: 26365597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis.
    Cinar SL; Kartal D; Bayram AK; Canpolat M; Borlu M; Ferahbas A; Per H
    Indian J Dermatol Venereol Leprol; 2017; 83(1):27-32. PubMed ID: 27643542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex : A Randomized Clinical Trial.
    Wataya-Kaneda M; Nakamura A; Tanaka M; Hayashi M; Matsumoto S; Yamamoto K; Katayama I
    JAMA Dermatol; 2017 Jan; 153(1):39-48. PubMed ID: 27837201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study of rapamycin or rapalog 0·1% cream for facial angiofibromas in tuberous sclerosis complex: evaluation of treatment effectiveness and cost.
    Norrenberg S; Masconi M; Karamanou M; Meylan P; Golaz R; Christen-Zaech S
    Br J Dermatol; 2018 Jul; 179(1):208-209. PubMed ID: 29380350
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical use of mammalian target of rapamycin inhibitors in dermatology: A systematic review with meta-analysis.
    Leducq S; Giraudeau B; Tavernier E; Maruani A
    J Am Acad Dermatol; 2019 Mar; 80(3):735-742. PubMed ID: 30744877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis.
    Haemel AK; O'Brian AL; Teng JM
    Arch Dermatol; 2010 Jul; 146(7):715-8. PubMed ID: 20644030
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of Rapamycin in Tuberous Sclerosis-Associated Hypopigmented Macules: Back to the Future.
    Arbiser JL
    JAMA Dermatol; 2015 Jul; 151(7):703-4. PubMed ID: 25692853
    [No Abstract]   [Full Text] [Related]  

  • 14. Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex.
    Koenig MK; Butler IJ; Northrup H
    J Child Neurol; 2008 Oct; 23(10):1238-9. PubMed ID: 18952591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex.
    Ebrahimi-Fakhari D; Agricola KD; Tudor C; Krueger D; Franz DN
    Pediatr Neurol; 2020 Apr; 105():59-61. PubMed ID: 31924480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effects of Topical 0.2% Sirolimus for Angiofibromas in Adults and Pediatric Patients with Tuberous Sclerosis Complex.
    Lee YI; Lee JH; Kim DY; Chung KY; Shin JU
    Dermatology; 2018; 234(1-2):13-22. PubMed ID: 29925060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis complex.
    Balestri R; Neri I; Patrizi A; Angileri L; Ricci L; Magnano M
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):14-20. PubMed ID: 25174683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and characterization of a 0.1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas.
    Bouguéon G; Lagarce F; Martin L; Pailhoriès H; Bastiat G; Vrignaud S
    Int J Pharm; 2016 Jul; 509(1-2):279-284. PubMed ID: 27260135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: follow up of a pilot study and promising future directions.
    Tu J; Foster RS; Bint LJ; Halbert AR
    Australas J Dermatol; 2014 Feb; 55(1):63-9. PubMed ID: 24359523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambient-stable topical rapamycin cream is effective in treating angiofibromas in tuberous sclerosis complex.
    Hong CH; Lee CH
    Br J Dermatol; 2023 Oct; 189(5):507-508. PubMed ID: 37672663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.